Cosmos Health Inc. (NASDAQ:COSM) Sees Significant Growth in Short Interest

Posted by on Jun 30th, 2026

Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 2,343,632 shares, an increase of 163.2% from the May 31st total of 890,287 shares. Based on an average trading volume of 14,830,375 shares, the days-to-cover ratio is presently 0.2 days. Approximately 5.1% of the company’s shares are sold short.

Cosmos Health Price Performance

NASDAQ:COSM traded up $0.00 during mid-day trading on Tuesday, hitting $0.18. 31,710,682 shares of the company’s stock traded hands, compared to its average volume of 3,379,019. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.92 and a current ratio of 1.08. The firm’s 50 day simple moving average is $0.28 and its 200 day simple moving average is $0.37. Cosmos Health has a 1 year low of $0.16 and a 1 year high of $1.32. The company has a market cap of $10.99 million, a PE ratio of -0.27 and a beta of 4.80.

Cosmos Health (NASDAQ:COSM – Get Free Report) last announced its earnings results on Thursday, May 21st. The company reported ($0.06) EPS for the quarter, meeting analysts’ consensus estimates of ($0.06). The firm had revenue of $18.40 million for the quarter, compared to analysts’ expectations of $17.93 million. Cosmos Health had a negative return on equity of 52.85% and a negative net margin of 30.41%. Sell-side analysts expect that Cosmos Health will post -0.06 EPS for the current year.

Insider Activity at Cosmos Health

In other news, CEO Grigorios Siokas purchased 218,447 shares of the stock in a transaction on Thursday, June 11th. The stock was bought at an average price of $0.21 per share, for a total transaction of $45,873.87. Following the acquisition, the chief executive officer directly owned 13,481,808 shares of the company’s stock, valued at approximately $2,831,179.68. The trade was a 1.65% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Georgios Terzis acquired 168,135 shares of Cosmos Health stock in a transaction dated Tuesday, June 16th. The shares were bought at an average price of $0.25 per share, with a total value of $42,033.75. Following the transaction, the chief financial officer directly owned 2,235,398 shares in the company, valued at approximately $558,849.50. The trade was a 8.13% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased a total of 1,088,029 shares of company stock valued at $249,240 in the last quarter. 26.15% of the stock is owned by insiders.

Hedge Funds Weigh In On Cosmos Health

A number of institutional investors have recently modified their holdings of the company. Renaissance Technologies LLC boosted its position in Cosmos Health by 16.7% during the first quarter. Renaissance Technologies LLC now owns 390,500 shares of the company’s stock worth $124,000 after acquiring an additional 55,925 shares during the last quarter. XTX Topco Ltd increased its position in Cosmos Health by 52.1% during the fourth quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock worth $50,000 after purchasing an additional 34,117 shares during the last quarter. Finally, Citadel Advisors LLC grew its stake in shares of Cosmos Health by 133.1% during the 3rd quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock valued at $250,000 after buying an additional 128,776 shares during the period. Institutional investors and hedge funds own 12.61% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Cosmos Health in a research note on Monday, June 15th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

Check Out Our Latest Stock Analysis on Cosmos Health

Cosmos Health Company Profile

(Get Free Report)

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.

Featured Articles

Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.